NanoFuse Biologics, Inspan and Sacrix merged into Nanisx to push minimally invasive spine technologies. A CEO for Nanisx is expected to be announced in the near future.
NanoFuse Biologics focuses on bone healing and fusion with a fiber-based bioactive glass combined with a demineralized bone matrix. The company merged to form Nanisx to help build its team and expand its market share in orthobiologics.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
